AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
GLIBENCLAMIDE in Zimbabwe
4 products registered with MCAZ — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| GLIBENCLAMIDE TABLET; ORAL | 2004/17.7/4308 | MEDICAMEN BIOTECH LIMITED | active | 12 Jan 2030 |
| GLAMIDE TABLET; ORAL | 2003/17.7/4203 | CADILA PHARMACEUTICALS LIMITED | active | 20 Mar 2029 |
| VARIGLYBEN TABLET; ORAL | 92/17.7/2598 | VARICHEM PHARMACEUTICALS (PVT) LTD | active | 13 Mar 2029 |
| GLITISOL 5 TABLET; ORAL | 99/17.7/3621 | REMEDICA LTD | active | 31 Dec 2027 |
GLIBENCLAMIDE — MCAZ Registration Details
MCAZ (Zimbabwe) has 4 registered products containing GLIBENCLAMIDE, of which 4 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track GLIBENCLAMIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.